---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-012876"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:33:11.309002+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Onconetix appoints Ajit Singh and Thomas Meier to board of directors

## Summary
- Ajit Singh, PhD, appointed to fill vacancy created by Neil Campbell's resignation, effective Feb 8, 2024.
- Thomas Meier, PhD, also appointed; press release announced Feb 13, 2024.
- Singh is partner at Artiman Ventures, former CEO of Biolmagene (acquired by Roche), ex-global CEO of Siemens Oncology.
- Meier is co-founder of Santhera Pharmaceuticals, raised ~$300M, managed Raxone approval in Europe.

## SEC filing metadata
- accession: 0001213900-24-012876
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/0001213900-24-012876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/ea193550-8k_onconetix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-012876
- JSON: https://secwatch.observer/filing/0001213900-24-012876.json
- Plain text: https://secwatch.observer/filing/0001213900-24-012876.txt

## Key facts
- Executive change
  Ajit Singh was appointed as Director at Onconetix, Inc..
  - Action: appointed
  - Role: Director
  source text: On February 8, 2024, the Board of Directors (the “ Board ”) of the Company appointed Ajit Singh to fill the vacancy created by the resignation of Neil Campbell.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/0001213900-24-012876-index.htm
- Executive change
  Neil Campbell resigned as Director at Onconetix, Inc..
  - Action: resigned
  - Role: Director
  source text: On February 8, 2024, the Board of Directors (the “ Board ”) of the Company appointed Ajit Singh to fill the vacancy created by the resignation of Neil Campbell.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/0001213900-24-012876-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.